10week (4 days post infusion)
feeling great ! today is not a gym day. That is being reserved for mon. and Thursday only.
Incidentally I was told this morning that my more professional appointments should begin Mar 24 and also be two separate sessions twice a week so Thursdays will need to change.
The following is pasted in from a mail sent this morning: please understand my laziness in not wanting to recount it again.
After meeting with Dr. Kinkel and hearing his opinion on Zenapax which is similar to Tysabri http://www.cbc.ca/story/science/national/2004/11/24/ms041122.html in its mode of action and his overwhelming success in treating many of his patients with it, I received my first infusion.
After discussing my success with chemo and the progress I'm making with my own physical rehab in the pool and gym, work with my osteopath, and nutritionist GP I kicked both legs out, moved my feet and ankles ect. He was impressed and praised me for my attitude and progress to date.
His neurological institute (http://www.kinkelneurologic.com/index.htm in Buffalo was extremely warm in their reception of me and made me feel very relaxed and helped me see my decision was a very wise one.
Without over stating the regimens efficacy, his staff optimistically told me that I would not be the first to arrive seating and eventually leave them on my own two feet.
It was this medication that I had first heard of (and asked my neurologists about last Dec '04) and which had started
me down this road.
My next infusion is in a few weeks and then will be followed monthly.
MS is thought to be caused by an over-reactive immune response. T-lymphocytes (cells of the immune system), are thought to damage myelin, a substance that covers the nerve and parts of the spinal cord and is damaged in patients with MS. Interleukin-2 is a natural substance in the body that is necessary for the growth of T-lymphocytes.
Zenapax is a genetically engineered antibody that blocks the activity of interleukin-2 and thus interferes with the growth of lymphocytes. Therefore, Zenapax may prevent some of the damage to myelin that occurs in multiple sclerosis
Incidentally I was told this morning that my more professional appointments should begin Mar 24 and also be two separate sessions twice a week so Thursdays will need to change.
The following is pasted in from a mail sent this morning: please understand my laziness in not wanting to recount it again.
After meeting with Dr. Kinkel and hearing his opinion on Zenapax which is similar to Tysabri http://www.cbc.ca/story/science/national/2004/11/24/ms041122.html in its mode of action and his overwhelming success in treating many of his patients with it, I received my first infusion.
After discussing my success with chemo and the progress I'm making with my own physical rehab in the pool and gym, work with my osteopath, and nutritionist GP I kicked both legs out, moved my feet and ankles ect. He was impressed and praised me for my attitude and progress to date.
His neurological institute (http://www.kinkelneurologic.com/index.htm in Buffalo was extremely warm in their reception of me and made me feel very relaxed and helped me see my decision was a very wise one.
Without over stating the regimens efficacy, his staff optimistically told me that I would not be the first to arrive seating and eventually leave them on my own two feet.
It was this medication that I had first heard of (and asked my neurologists about last Dec '04) and which had started
me down this road.
My next infusion is in a few weeks and then will be followed monthly.
MS is thought to be caused by an over-reactive immune response. T-lymphocytes (cells of the immune system), are thought to damage myelin, a substance that covers the nerve and parts of the spinal cord and is damaged in patients with MS. Interleukin-2 is a natural substance in the body that is necessary for the growth of T-lymphocytes.
Zenapax is a genetically engineered antibody that blocks the activity of interleukin-2 and thus interferes with the growth of lymphocytes. Therefore, Zenapax may prevent some of the damage to myelin that occurs in multiple sclerosis
